Medical/Pharmaceuticals
Foresee Pharmaceuticals Announces Completion of US$47 Million Financing
TAIPEI, Dec. 24, 2020 /PRNewswire/ -- Foresee pharmaceuticals (TPEx: 6576.TWO) ("Foresee") announces that it has successfully completed an underwritten public offering of 15,000,000 shares of its common stock to the public at a price of NT$88 per share. The aggregate gross proceeds to Foresee from...
2020-12-24 18:00
10911
Senhwa Biosciences Receives US FDA 'Study May Proceed' Letter to Treat BRCA2+ or PALB2+ Solid Tumors With CX-5461
TAIPEI and SAN DIEGO, Dec. 23. 2020 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on next-generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, today announced that it has received a "Study May Proceed" letter fr...
2020-12-24 10:40
3302
Conbercept: New Generation of Product for Treatment of nAMD Completes 36-week Primary Endpoint Visits of Phase III Trial
CHENGDU, China, Dec. 23, 2020 /PRNewswire/ -- Chengdu Kanghong Pharmaceutical Group ("Kanghong") announced a key development milestone of its key product conbercept last month. Kanghong is seeking global approval of conbercept by undertaking a multicenter, multinational, double-masked, parallel-gr...
2020-12-23 22:40
6986
I-Mab Announces Upcoming Participation at January Conferences
SHANGHAI and GAITHERSBURG, Md., Dec. 23, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced its participation in the following conferences in Januar...
2020-12-23 21:00
5978
Hyundai Bioscience Develops Injection Drug for Potential Treatment of Severe Cases of COVID-19
SEOUL, South Korea, Dec. 22, 2020 /PRNewswire/ -- Hyundai Bioscience (KOSDAQ symbol: 048410) announced on the 23rd, December 2020, that CNPharm, its major shareholding bio tech company, has succeeded in developing 'Poly-COV01,' an injection drug for thepotential treatment of patients with severe ...
2020-12-23 10:09
2153
111, Inc. Announces Additional Round of New Capital Injection
SHANGHAI, Dec. 22, 2020 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading digital healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, today announced the successful completion of new capital injection in it...
2020-12-22 17:22
12202
Alterity and UniQuest partner to reverse bacterial resistance to antibiotics
MELBOURNE, Australia, Dec. 21, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") has today announced it has been granted a licence by UniQuest, the commercialisation company of The University of Queensland (UQ), to novel zinc ionophore technology to ...
2020-12-22 05:42
6286
DW Healthcare Partners V, L.P. Announces Commencement of the Tender Offer for All Outstanding Ordinary Shares of Parnell Pharmaceuticals Holdings Ltd
PARK CITY, Utah, Dec. 22, 2020 /PRNewswire/ -- DW Healthcare Partners V, L.P. ("Purchaser"), announced today that it has commenced a cash tender offer for all of the outstanding ordinary shares of Parnell Pharmaceuticals Holdings Ltd (OTC Pink Open Market: PARNF) ("Parnell") at a price of U.S.$0....
2020-12-21 23:07
14145
Pierre Fabre Selects AGC Biologics as CDMO to manufacture the orphan drug ER-004
SEATTLE, Dec. 21, 2020 /PRNewswire/ -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced its partnership with Laboratoire Pierre Fabre to manufacture ER-004 – an intra-amniotic drug that will pioneer the treatment of a rare and...
2020-12-21 23:00
1911
Major Breakthrough: DragonFly-T™ First Transcatheter Tricuspid Valve Repair Surgery in China
HANGZHOU, China, Dec. 21, 2020 /PRNewswire/ -- On December 15, 2020, Professor Wang Jian'an's team from the Second Hospital of Zhejiang University School of Medicine successfully applied the DragonFly-T™ Transcatheter Tricuspid Valve Clamping System to perform the first human clinical application...
2020-12-21 22:18
2130
Longevity Acquisition Corporation Announces 4D pharma Joining Landmark Parkinson's Progression Markers Initiative
NEW YORK, Dec. 21, 2020 /PRNewswire/ -- Longevity Acquisition Corporation (NASDAQ: LOAC) (the "Company"), a publicly-traded special purpose acquisition company, announced today that onDecember 18, 2020, 4D pharma plc (AIM: DDDD) ("4D pharma"), a pharmaceutical company leading the development of L...
2020-12-21 21:00
11278
ImmuneMed's hzVSF-v13, COVID-19 clinical trials accelerate development of the treatment
Followed by Russia, Indonesia, and Korea, the second phase of the COVID-19 clinical trial was approved inItaly on Friday, December 18, 2020. CHUNCHEON, South Korea, Dec. 20, 2020 /PRNewswire/ -- The broad spectrum antiviral therapeutic, 'hzVSF-v13(humanized Virus Suppressing Factor)' being devel...
2020-12-21 10:43
1399
Peijia Medical and HighLife Enter Into License and Technology Transfer Agreement for Transeptal Mitral Valve Replacement in Greater China
SUZHOU, China and PARIS, Dec. 20, 2020 /PRNewswire/ -- Peijia Medical Ltd (HK Stock Code: 09996) and HighLife SAS, aParis-based medical device company, focused on the development of a unique transeptal mitral valve replacement ("TMVR") system to treat patients suffering from mitral regurgitation,...
2020-12-21 10:00
4115
Teijin Pharma and TransThera Biosciences Form Strategic R&D Collaboration
TOKYO and NANJING, China, Dec. 18, 2020 /PRNewswire/ -- Teijin Pharma Limited
2020-12-18 23:30
3877
Medtecs Chosen as Asian Development Bank's Partner to Supply Vital PPE to Asian Developing Countries Amidst COVID-19 Pandemic
TAIPEI, Dec. 18, 2020 /PRNewswire/ -- Medtecs Group, a leading personal protective equipment (PPE) supplier based inTaiwan, had passed the rigorous procurement process of the Asian Development Bank (ADB) inJune 2020 to become the ADB's supplier of critical protective gear for frontline health wor...
2020-12-18 18:22
2557
Amidst COVID-19 Pandemic, Medtecs Group Transforms Itself into the World's Biggest Stockpiling Solutions Provider
TAIPEI, Dec. 18, 2020 /PRNewswire/ -- Taiwan has been lauded by international communities for its standout performance in containing the outbreak of the coronavirus (COVID-19). In the meantime, Medtecs Group, a company headquartered inTaipei, Taiwan has taken off to become the world's leading sup...
2020-12-18 15:27
1890
I Peace, Inc. and Avery Therapeutics announce collaboration to bring iPSC derived cell therapy for heart failure to the clinic
I Peace's GMP-grade iPSCs are key to manufacture Avery Therapeutics' MyCardia™, a proprietary tissue-engineered heart graft developed to treat heart failure TUCSON, Ariz. and PALO ALTO, Calif., Dec. 16, 2020 /PRNewswire/ -- Avery Therapeutics, aTucson-based company dedicated to advancing tissue-e...
2020-12-17 08:41
2097
New data confirms Smith+Nephew technology as the best performing cementless construct for Total Hip Arthroplasty¹
Components of the POLAR3™ Total Hip Solution excel at ten and fifteen year benchmarks in global registries LONDON, Dec. 16, 2020 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announced outstanding clinical results for its total hip arthroplasty (T...
2020-12-16 21:00
6883
Samsung Biologics Names John Rim as President and CEO
INCHEON, South Korea, Dec. 16, 2020 /PRNewswire/ -- Samsung Biologics (KRX:
207940.KS) announcedJohn Rim as its President and CEO. The appointment was made
effective immediately and formalized via the company's board of directors
meeting today.
2020-12-16 20:00
1988
Clarity Pharmaceuticals closes $25m capital raising
SYDNEY, Dec. 15, 2020 /PRNewswire/ -- Clarity Pharmaceuticals, a clinical stage radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that it has completed a capital raising of$25,000,410. Dr Alan Taylor, Executive Chairman of Clarity Pharmaceuticals, co...
2020-12-15 22:12
2470
Week's Top Stories
Most Reposted
Tonik raises US$12M Pre-Series C to scale capital-efficient lending in the Philippines
[Picked up by 318 media titles]
2025-12-04 10:15
Hyundai Motor Group and Air Liquide Advance Global Partnership to Accelerate Hydrogen Ecosystem
[Picked up by 311 media titles]
2025-12-04 16:00
Klook takes the lead among international travelers booking paid tours and activities in Japan
[Picked up by 309 media titles]
2025-12-04 13:12
World-Leading Microsurgeon Professor J.P. Hong Joins MediThinQ as CMO, Marking Strong Validation for Next-Generation Digital Microsurgery
[Picked up by 297 media titles]
2025-12-03 09:00
Hyundai Motor Group Fosters Collaboration with Hydrogen Industry Leaders at Hydrogen Council Global CEO Summit
[Picked up by 295 media titles]
2025-12-04 15:00
Most Read
Abu Dhabi signs agreements and explores opportunities to strengthen partnerships with India and Singapore
2025-12-06 09:00
4302
Taipei City's Global Pass: A New Partner Channel for Global Startup Spaces
2025-12-06 01:06
3526
MALAYSIA REMAINS COMMITTED TO ACCELERATE TRANSFORMATIVE SOLUTIONS FOR A SUSTAINABLE AND INCLUSIVE FUTURE
2025-12-06 00:41
3487
Dreame Technology Recognized on Fast Company's List of Brands That Matter
2025-12-06 01:30
3176
